Antigenic Phenotype of Cultured Human Osteoblast-Like Cells

Department of Stomatology, Immunology Section, Institute of Neuroscience, University of Granada, Madrid, Spain.
Cellular Physiology and Biochemistry (Impact Factor: 2.88). 02/2002; 12(5-6):359-64. DOI: 10.1159/000067906
Source: PubMed


Osteoblasts are classically considered to play an important role during bone tissue development, and to be involved in the formation of mineralized bone matrix. Recent reports have suggested that they can also exert some activities directly associated with the immune system (cytokine synthesis and antigen presentation). Moreover, some authors have found antigens on osteoblast-like cells normally expressed by other cells with a common origin in bone marrow.
We isolated and cultured human osteoblast-like lines and studied their antigenic phenotype with flow cytometry using monoclonal antibodies against antigens associated with hematopoietic cells.
Cultured cells expressed CD34, but were negative for CD45. B cell antigens CD20 and CD23 and myelomonocytic antigens CD11b, CD13, and CD16 were detected. Expression of CD3, CD14, CD15 and CD68 was negative, whereas CD25 expression was positive. CD56, an antigen expressed on NK cells, was positive. These cells were CD10, CD44, CD54, CD80, CD86 and HLA-DR positive, as previously described. An antigen specific to follicular dendritic cells was also observed on cultured osteoblast-like cells.
The antigenic phenotypes of human osteoblast-like cells and FDC are similar. These data suggest that osteoblasts may be functionally related to certain dendritic cells and may play an additional role in bone tissue to that classically assigned.

  • Source
    • "In our results, we revealed that dioscin could significantly increase ALP activity and up-regulate Bcl-2 expression level in MC3T3-E1 cells. Because MG-63 cell line has a similar antigenic prolife to that in primary cultured human osteoblasts from human bone tissue sections [32,33], therefore, we also detected the promoting effects of doscin on osteoblasts by using this human osteoblast-like cells. And the results indicated that dioscin could also promote the proliferation and differentiation of MG-63 cells significantly. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dioscin, a typical steroid saponin, is isolated from Dioscorea nipponica Makino and Dioscorea zingiberensis Wright. It has estrogenic activity and many studies have also reported that dioscorea plants have an effect in preventing and treating osteoporosis. However, the molecular mechanisms underlying their effect on osteoporosis treatment are poorly understood. Therefore, the present study aims to investigate the mechanism (s) by which dioscin promotes osteoblastic proliferation and differentiation in mouse pre-osteoblast like MC3T3-E1 cells and human osteoblast-like MG-63 cells. We found that dioscin (0.25 mug/ml, 0.5 mug/ml, and 1.0 mug/ml) promoted MC3T3-E1 cells and MG-63 cells proliferation and differentiation dose dependently. Western blot analysis results showed that estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta), beta-catenin and Bcl-2 protein expression increased after MC3T3-E1 cells were treated with dioscin. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis indicated that dioscin could increase the ratio of osteoprotegerin (OPG)/ receptor activator of NF-kappaB ligand (RANKL) and up-regulate the level of Lrp5 and beta-catenin. And by RNA interference analysis, we proved that the effect of dioscin increasing the ratio of OPG/ RANKL was dependent on Lrp5 pathway. In addition, we also found that these effects of dioscin were abolished by ICI 182, 780 (100 nM), an antagonist of ER, indicating that an ER signaling pathway was also involved. We also found that dioscin (0.25 mug/ml, 0.5 mug/ml, and 1.0 mug/ml) induced MG-63 cells proliferation and differentiation in a dose-dependent manner. Western blot analysis results indicated that ER-alpha, ER-beta and beta-catenin protein expression increased after MG-63 cells were treated with dioscin. The current study is the first to reveal that dioscin can promote osteoblasts proliferation and differentiation via Lrp5 and ER pathway.
    Full-text · Article · Apr 2014 · Journal of Biomedical Science
  • Source
    • "Research has focused on the activity of osteoblasts, which play an important role in bone formation and regeneration and are reported to have both bone-forming and immunological functions. We draw attention to: the high expression of antigens involved in antigen presentation in bone tissue sections8, primary cultures, and human osteosarcoma cell line MG-639, 10, 11, 12; the elevated expression of various cytokines13, 14; and their phagocytic capacity of osteoblasts against targets of different size and nature11, 12. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To examine the effects of acetaminophen (paracetamol), a nonsteroidal anti-inflammatory drug (NSAID), on different cellular and functional parameters of the human osteosarcoma cell line MG63. Flow cytometry was used to study proliferation, antigenic profile, and phagocytic activity, and radioimmunoassay was used to determine osteocalcin synthesis as a cell differentiation marker. Short-term treatment with therapeutic doses of paracetamol(5 or 25 μmol/L) reduced cell proliferation, osteocalcin synthesis, and phagocyte activity, and increased the expression of antigens involved in antigen presentation to T lymphocytes (CD80, CD86, HLA-DR). These findings suggest that paracetamol activates the osteoblast, inducing its immunogenic action to the detriment of its bone formation capacity.
    Full-text · Article · Nov 2010 · Acta Pharmacologica Sinica
    • "Among the genes constitutively up-regulated in BRM-depleted cells is Akp2, encoding alkaline phosphatase, a major osteoblast differentiation marker whose increase was also apparent at the level of enzyme activity (Fig. 1). The remainder of the list encompasses genes from multiple classes, including those encoding hematopoietic cell-associated antigen CD11b (Itgam) and the widely expressed CD36 antigen, both of which have been observed in differentiating osteoblasts (29, 30). Genes encoding various extracellular matrix components (DMP1, collagen 11, and tuftelin) are activated. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The mammalian SWI/SNF chromatin-remodeling complex is essential for the multiple changes in gene expression that occur during differentiation. However, the basis within the complex for specificity in effecting positive versus negative changes in gene expression has only begun to be elucidated. The catalytic core of the complex can be either of two closely related ATPases, BRM or BRG1, with the potential that the choice of alternative subunits is a key determinant of specificity. Short hairpin RNA-mediated depletion of the ATPases was used to explore their respective roles in the well characterized multistage process of osteoblast differentiation. The results reveal an unexpected role for BRM-specific complexes. Instead of impeding differentiation as was seen with BRG1 depletion, depletion of BRM caused accelerated progression to the differentiation phenotype. Multiple tissue-specific differentiation markers, including the tightly regulated late stage marker osteocalcin, become constitutively up-regulated in BRM-depleted cells. Chromatin immunoprecipitation analysis of the osteocalcin promoter as a model for the behavior of the complexes indicates that the promoter is a direct target of both BRM- and BRG1-containing complexes. BRG1 complexes, which are required for activation, are associated with the promoter well before induction, but the concurrent presence of BRM-specific complexes overrides their activation function. BRM-specific complexes are present only on the repressed promoter and are required for association of the co-repressor HDAC1. These findings reveal an unanticipated degree of specialization of function linked with the choice of ATPase and suggest a new paradigm for the roles of the alternative subunits during differentiation.
    No preview · Article · Feb 2009 · Journal of Biological Chemistry
Show more